Literature DB >> 26694805

Creation and characterization of an airway epithelial cell line for stable expression of CFTR variants.

Laura B Gottschalk1, Briana Vecchio-Pagan1, Neeraj Sharma1, Sangwoo T Han1, Arianna Franca1, Elizabeth S Wohler2, Denise A S Batista2, Loyal A Goff3, Garry R Cutting4.   

Abstract

BACKGROUND: Analysis of the functional consequences and treatment response of rare CFTR variants is challenging due to the limited availability of primary airways cells.
METHODS: A Flp recombination target (FRT) site for stable expression of CFTR was incorporated into an immortalized CF bronchial epithelial cell line (CFBE41o-). CFTR cDNA was integrated into the FRT site. Expression was evaluated by western blotting and confocal microscopy and function measured by short circuit current. RNA sequencing was used to compare the transcriptional profile of the resulting CF8Flp cell line to primary cells and tissues.
RESULTS: Functional CFTR was expressed from integrated cDNA at the FRT site of the CF8Flp cell line at levels comparable to that seen in native airway cells. CF8Flp cells expressing WT-CFTR have a stable transcriptome comparable to that of primary cultured airway epithelial cells, including genes that play key roles in CFTR pathways.
CONCLUSION: CF8Flp cells provide a viable substitute for primary CF airway cells for the analysis of CFTR variants in a native context.
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CFBE; CFTR; Cystic fibrosis model; Ivacaftor; RNA sequencing

Mesh:

Substances:

Year:  2015        PMID: 26694805      PMCID: PMC4879073          DOI: 10.1016/j.jcf.2015.11.010

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  31 in total

1.  Differential properties among clones of simian virus 40-transformed human epithelial cells.

Authors:  M E Kaighn; K S Narayan; Y Ohnuki; L W Jones; J F Lechner
Journal:  Carcinogenesis       Date:  1980-08       Impact factor: 4.944

2.  MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms.

Authors:  A P Singh; S C Chauhan; M Andrianifahanana; N Moniaux; J L Meza; M C Copin; I van Seuningen; M A Hollingsworth; J P Aubert; S K Batra
Journal:  Oncogene       Date:  2006-06-26       Impact factor: 9.867

3.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Authors:  Claire E Wainwright; J Stuart Elborn; Bonnie W Ramsey; Gautham Marigowda; Xiaohong Huang; Marco Cipolli; Carla Colombo; Jane C Davies; Kris De Boeck; Patrick A Flume; Michael W Konstan; Susanna A McColley; Karen McCoy; Edward F McKone; Anne Munck; Felix Ratjen; Steven M Rowe; David Waltz; Michael P Boyle
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

4.  Differential analysis of gene regulation at transcript resolution with RNA-seq.

Authors:  Cole Trapnell; David G Hendrickson; Martin Sauvageau; Loyal Goff; John L Rinn; Lior Pachter
Journal:  Nat Biotechnol       Date:  2012-12-09       Impact factor: 54.908

5.  Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle.

Authors:  Alan R Brooks; Richard N Harkins; Peiyin Wang; Hu Sheng Qian; Pengxuan Liu; Gabor M Rubanyi
Journal:  J Gene Med       Date:  2004-04       Impact factor: 4.565

6.  Some gating potentiators, including VX-770, diminish ΔF508-CFTR functional expression.

Authors:  Guido Veit; Radu G Avramescu; Doranda Perdomo; Puay-Wah Phuan; Miklos Bagdany; Pirjo M Apaja; Florence Borot; Daniel Szollosi; Yu-Sheng Wu; Walter E Finkbeiner; Tamas Hegedus; Alan S Verkman; Gergely L Lukacs
Journal:  Sci Transl Med       Date:  2014-07-23       Impact factor: 17.956

7.  Synergy-based small-molecule screen using a human lung epithelial cell line yields ΔF508-CFTR correctors that augment VX-809 maximal efficacy.

Authors:  Puay-Wah Phuan; Guido Veit; Joseph Tan; Ariel Roldan; Walter E Finkbeiner; Gergely L Lukacs; A S Verkman
Journal:  Mol Pharmacol       Date:  2014-04-15       Impact factor: 4.436

8.  Expression of cystic fibrosis transmembrane conductance regulator in a model epithelium.

Authors:  D N Sheppard; M R Carson; L S Ostedgaard; G M Denning; M J Welsh
Journal:  Am J Physiol       Date:  1994-04

9.  Targeted replacement of normal and mutant CFTR sequences in human airway epithelial cells using DNA fragments.

Authors:  K K Goncz; K Kunzelmann; Z Xu; D C Gruenert
Journal:  Hum Mol Genet       Date:  1998-11       Impact factor: 6.150

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  18 in total

1.  Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis.

Authors:  Allison F McCague; Karen S Raraigh; Matthew J Pellicore; Emily F Davis-Marcisak; Taylor A Evans; Sangwoo T Han; Zhongzhou Lu; Anya T Joynt; Neeraj Sharma; Carlo Castellani; Joseph M Collaco; Mary Corey; Michelle H Lewis; Chris M Penland; Johanna M Rommens; Anne L Stephenson; Patrick R Sosnay; Garry R Cutting
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

2.  Functional Assays Are Essential for Interpretation of Missense Variants Associated with Variable Expressivity.

Authors:  Karen S Raraigh; Sangwoo T Han; Emily Davis; Taylor A Evans; Matthew J Pellicore; Allison F McCague; Anya T Joynt; Zhongzhou Lu; Melis Atalar; Neeraj Sharma; Molly B Sheridan; Patrick R Sosnay; Garry R Cutting
Journal:  Am J Hum Genet       Date:  2018-05-24       Impact factor: 11.025

Review 3.  Transformative therapies for rare CFTR missense alleles.

Authors:  Kathryn E Oliver; Sangwoo T Han; Eric J Sorscher; Garry R Cutting
Journal:  Curr Opin Pharmacol       Date:  2017-10-13       Impact factor: 5.547

4.  Evaluation of 1,2,3-Triazoles as Amide Bioisosteres In Cystic Fibrosis Transmembrane Conductance Regulator Modulators VX-770 and VX-809.

Authors:  Jake E Doiron; Christina A Le; Britton K Ody; Jonathon B Brace; Savannah J Post; Nathan L Thacker; Harrison M Hill; Gary W Breton; Matthew J Mulder; Sichen Chang; Thomas M Bridges; Liping Tang; Wei Wang; Steven M Rowe; Stephen G Aller; Mark Turlington
Journal:  Chemistry       Date:  2019-02-11       Impact factor: 5.236

5.  Functional Genomics of ABCA3 Variants.

Authors:  Jennifer A Wambach; Ping Yang; Daniel J Wegner; Hillary B Heins; Cliff Luke; Fuhai Li; Frances V White; F Sessions Cole
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

6.  Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis.

Authors:  Anh-Thu N Lam; Melis A Aksit; Briana Vecchio-Pagan; Celeste A Shelton; Derek L Osorio; Arianna F Anzmann; Loyal A Goff; David C Whitcomb; Scott M Blackman; Garry R Cutting
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

7.  Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.

Authors:  Sangwoo T Han; Andras Rab; Matthew J Pellicore; Emily F Davis; Allison F McCague; Taylor A Evans; Anya T Joynt; Zhongzhou Lu; Zhiwei Cai; Karen S Raraigh; Jeong S Hong; David N Sheppard; Eric J Sorscher; Garry R Cutting
Journal:  JCI Insight       Date:  2018-07-26

8.  Screening for Regulatory Variants in 460 kb Encompassing the CFTR Locus in Cystic Fibrosis Patients.

Authors:  Jenny L Kerschner; Sujana Ghosh; Alekh Paranjapye; Wilmel R Cosme; Marie-Pierre Audrézet; Miyuki Nakakuki; Hiroshi Ishiguro; Claude Férec; Johanna Rommens; Ann Harris
Journal:  J Mol Diagn       Date:  2018-10-05       Impact factor: 5.568

Review 9.  CFTR modulator theratyping: Current status, gaps and future directions.

Authors:  John Paul Clancy; Calvin U Cotton; Scott H Donaldson; George M Solomon; Donald R VanDevanter; Michael P Boyle; Martina Gentzsch; Jerry A Nick; Beate Illek; John C Wallenburg; Eric J Sorscher; Margarida D Amaral; Jeffrey M Beekman; Anjaparavanda P Naren; Robert J Bridges; Philip J Thomas; Garry Cutting; Steven Rowe; Anthony G Durmowicz; Martin Mense; Kris D Boeck; William Skach; Christopher Penland; Elizabeth Joseloff; Hermann Bihler; John Mahoney; Drucy Borowitz; Katherine L Tuggle
Journal:  J Cyst Fibros       Date:  2018-06-20       Impact factor: 5.482

10.  A deep learning approach to identify gene targets of a therapeutic for human splicing disorders.

Authors:  Dadi Gao; Elisabetta Morini; Monica Salani; Aram J Krauson; Anil Chekuri; Neeraj Sharma; Ashok Ragavendran; Serkan Erdin; Emily M Logan; Wencheng Li; Amal Dakka; Jana Narasimhan; Xin Zhao; Nikolai Naryshkin; Christopher R Trotta; Kerstin A Effenberger; Matthew G Woll; Vijayalakshmi Gabbeta; Gary Karp; Yong Yu; Graham Johnson; William D Paquette; Garry R Cutting; Michael E Talkowski; Susan A Slaugenhaupt
Journal:  Nat Commun       Date:  2021-06-07       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.